Indication
PD-1 Inhibitors
3 clinical trials
1 product
2 drugs
Clinical trial
PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II TrialStatus: Active (not recruiting), Estimated PCD: 2023-12-31
Drug
PD-1 inhibitorsClinical trial
Prospective, Single-arm Phase II Exploratory Study of the Efficacy and Safety of IBI110 Combined With Sintilimab in Advanced or Metastatic Esophageal Squamous Cell Carcinoma That Has Failed First-line Anti-PD-1 Antibody TherapyStatus: Not yet recruiting, Estimated PCD: 2024-10-01
Product
IBI110+SintilimabClinical trial
A Retrospective Clinical Study of Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Carcinoma.Status: Completed, Estimated PCD: 2023-05-21